Komal Rathi

Affiliations: 
2016- Biomedical and Health Informatics Children’s Hospital of Philadelphia / University of Pennsylvania, Philadelphia, PA, United States 
Google:
"Komal Rathi"
Mean distance: (not calculated yet)
 
Cross-listing: Computational Biology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Weiner AK, Radaoui AB, Tsang M, et al. (2023) A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma. Biorxiv : the Preprint Server For Biology
Krytska K, Casey CE, Pogoriler J, et al. (2022) Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma. Cancer Research Communications. 2: 616-623
Dang MT, Gonzalez MV, Gaonkar KS, et al. (2021) Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality. Cell Reports. 34: 108917
Shields CE, Potlapalli S, Cuya-Smith SM, et al. (2021) Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target. Molecular Oncology
Lopez G, Conkrite KL, Doepner M, et al. (2020) Somatic structural variation targets neurodevelopmental genes and identifies as a tumor suppressor in neuroblastoma. Genome Research
McDonald JT, Stainforth R, Miller J, et al. (2020) NASA GeneLab Platform Utilized for Biological Response to Space Radiation in Animal Models. Cancers. 12
Nabbi A, Sun P, Sumedha S, et al. (2020) Abstract PR06: The immunogenomic landscape of pediatric primary solid tumors Cancer Research. 80
Chen D, Cox J, Annam J, et al. (2020) Abstract B48: A LIN28B-PDZ kinase axis promotes neuroblastoma metastasis Cancer Research. 80
Shields CE, Cuya SM, Chappell S, et al. (2020) Abstract A47: BMI1 constitutes a novel therapeutic vulnerability in fusion-positive rhabdomyosarcoma Cancer Research. 80
Raman P, Zimmerman S, Rathi KS, et al. (2019) A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data. Cancer Genetics. 235: 1-12
See more...